Thymic microenvironmental alterations in experimentally induced diabetes.

[1]  L. Velloso,et al.  Leptin Action in the Thymus , 2009, Annals of the New York Academy of Sciences.

[2]  J. She,et al.  Type 1 diabetes patients have significantly lower frequency of plasmacytoid dendritic cells in the peripheral blood. , 2008, Clinical immunology.

[3]  G. Sempowski,et al.  Cytokines, leptin, and stress‐induced thymic atrophy , 2008, Journal of leukocyte biology.

[4]  W. Savino,et al.  Multivectorial Abnormal Cell Migration in the NOD Mouse Thymus1 , 2008, The Journal of Immunology.

[5]  M. Spielmann,et al.  Enhanced susceptibility to infections in a diabetic wound healing model , 2008, BMC surgery.

[6]  G. Take,et al.  Ultrastructure of the thymus in diabetes mellitus and starvation , 2008, Advances in therapy.

[7]  M. Ciofani,et al.  The thymus as an inductive site for T lymphopoiesis. , 2007, Annual review of cell and developmental biology.

[8]  L. Velloso,et al.  The thymus is a common target in malnutrition and infection , 2007, British Journal of Nutrition.

[9]  C. Scavone,et al.  Neutrophil function and metabolism in individuals with diabetes mellitus. , 2007, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[10]  A. Cooke,et al.  An early age‐related increase in the frequency of CD4+ Foxp3+ cells in BDC2·5NOD mice , 2007, Immunology.

[11]  Tony J Collins,et al.  ImageJ for microscopy. , 2007, BioTechniques.

[12]  H. Petrie,et al.  Zoned out: functional mapping of stromal signaling microenvironments in the thymus. , 2007, Annual review of immunology.

[13]  B. Nordestgaard,et al.  Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome , 2007, Diabetologia.

[14]  E. Bernotiene,et al.  The role of leptin in innate and adaptive immune responses , 2006, Arthritis research & therapy.

[15]  W. Savino.  The Thymus Is a Common Target Organ in Infectious Diseases , 2006, PLoS pathogens.

[16]  J. Silva,et al.  Altered thymocyte migration during experimental acute Trypanosoma cruzi infection: combined role of fibronectin and the chemokines CXCL12 and CCL4 , 2006, European journal of immunology.

[17]  Y. Takahama,et al.  Journey through the thymus: stromal guides for T-cell development and selection , 2006, Nature Reviews Immunology.

[18]  F. Schellevis,et al.  Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  W. Savino,et al.  Growth hormone modulates thymocyte development in vivo through a combined action of laminin and CXC chemokine ligand 12. , 2005, Endocrinology.

[20]  M. Martins,et al.  Thymus involution in alloxan diabetes: analysis of mast cells. , 2005, Memorias do Instituto Oswaldo Cruz.

[21]  W. Savino,et al.  Fibronectin Receptor Defects in NOD Mouse Leucocytes: Possible Consequences for Type 1 Diabetes , 2004, Scandinavian journal of immunology.

[22]  W. Savino,et al.  Molecular mechanisms governing thymocyte migration: combined role of chemokines and extracellular matrix , 2004, Journal of leukocyte biology.

[23]  I. Riederer,et al.  Trypanosoma cruzi infection modulates intrathymic contents of extracellular matrix ligands and receptors and alters thymocyte migration , 2003, European journal of immunology.

[24]  M. Martins,et al.  Systemic anaphylaxis is prevented in alloxan-diabetic rats by a mechanism dependent on glucocorticoids. , 2003, European journal of pharmacology.

[25]  B. Decallonne,et al.  The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression. , 2003, Journal of biomolecular techniques : JBT.

[26]  Graham M Lord,et al.  Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. , 1999, The Journal of clinical investigation.

[27]  P. Donohoue,et al.  Plasma leptin in diabetic and insulin-treated diabetic and normal rats. , 1998, Metabolism: clinical and experimental.

[28]  J. Dötsch,et al.  Serum leptin levels in children and adolescents with insulin-dependent diabetes mellitus in relation to metabolic control and body mass index. , 1998, European journal of endocrinology.

[29]  B. Genetet,et al.  Impaired Leucocyte Functions in Diabetic Patients , 1997, Diabetic medicine : a journal of the British Diabetic Association.

[30]  G. Gaulton,et al.  Assessment of the diabetogenic drugs alloxan and streptozotocin as models for the study of immune defects in diabetic mice , 1985, Diabetologia.

[31]  Y. Okuno,et al.  Maturational impairment of thymic lymphocytes in streptozotocin-induced diabetes in rats. , 1984, Cellular immunology.

[32]  E. Duffy,et al.  Further observations on the effects of alloxan on the pancreatic islets , 1944, The Journal of physiology.

[33]  D. Kleiner,et al.  Type 1 diabetes associated with acquired generalized lipodystrophy and insulin resistance: the effect of long-term leptin therapy. , 2008, The Journal of clinical endocrinology and metabolism.

[34]  J. Gameiro,et al.  Thymic alterations in Plasmodium berghei-infected mice. , 2008, Cellular immunology.

[35]  R. Borojevic,et al.  Laminin-211 controls thymocyte--thymic epithelial cell interactions. , 2008, Cellular immunology.

[36]  N. Mito,et al.  Analysis of the effect of leptin on immune function in vivo using diet-induced obese mice. , 2004, The Journal of endocrinology.